Quad TechnologiesQuad Technologies is transforming cell and gene therapy bioprocessing. Developments in cell therapies such as CAR-T and TCR to treat difficult indications such as leukemia have been growing exponentially. Manufacturing processes for these therapeutic products however, are onerous, poorly controlled, and antiquated. To address these critical challenges, we develop bio-manufacturing solutions based on a dissolvable hydrogel technology platform called QuickGel™. QuickGel provides a reproducible approach for controlled delivery of ligands to specific cell types critical to immuno-oncology, such as T cell activation and expansion. In addition, QuickGel offers rapid, simple, gentle, scalable and cost-effective approaches to the purification of multiple cell types. As a result, QuickGel creates a single solution that can be applied across a broad range of high-growth applications in life science research and bio-manufacturing processes.